Cassandra Jenkins on Muck Rack

Cassandra Jenkins

Philadelphia
As seen in: Healio, Healio Allergy/Asthma, Healio Cardiology, Healio Dermatology, Healio Gastroenterology, Healio Neurology, Healio Ophthalmology, Healio Primary Care, HemOnc Today, Nephrology News & Issues, Primary Care Optometry News and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Cassandra

Contact Cassandra, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Etrasimod can be safely used alongside opioids, antidepressants in ulcerative colitis

|
By Cassandra Jenkins, Heather Biele Verified
| Healio Gastroenterology Verified
Key takeaways: The incidence of adverse events potentially related to serotonin syndrome was low and similar across all subgroups of patients. No adverse events were serious or led to treatment discontinuation. Using etrasimod with opioids or antidepressants did not increase risk for serotonin syndrome-associated adverse events among patients with ulcerative colitis, according to a study published in United European Gastroenterology Journal.
Open in Who Shared Issue with article?

‘No beneficial effects’ from simvastatin plus rifaximin for decompensated cirrhosis

|
By Cassandra Jenkins, Heather Biele Verified
| Healio Gastroenterology Verified
Key takeaways: Patients who received simvastatin plus rifaximin experienced similar rates of complications as those treated with placebo. Incidence of adverse events was high in both treatment and placebo groups. The addition of simvastatin plus rifaximin to standard therapy did not improve outcomes among patients with decompensated cirrhosis who were at high risk for clinical complications, according to a study published in JAMA.
Open in Who Shared Issue with article?

IgG-guided elimination diet effectively reduces IBS-related abdominal pain

|
By Cassandra Jenkins, Heather Biele Verified, Prashant Singh Verified
| Healio Gastroenterology Verified
Key takeaways: More than half of the adults with IBS on an IgG-guided elimination diet reported reduced abdominal pain. Those who had IBS with constipation or mixed bowel habits benefited most from the experimental diet. Adults with irritable bowel syndrome who followed an IgG-guided elimination diet were more likely to experience a reduction in abdominal pain than those on a sham elimination diet, according to a study published in Gastroenterology.
Open in Who Shared Issue with article?
See all 321 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified